Clinical Trials of Cancer

A section of Cancers (ISSN 2072-6694).

Section Information

Cancers seeks to publish interesting articles reporting results of early or late phase clinical trials on any topic connected with clinical oncology. Topics include, but are not limited to, the following:

  • Breast cancer
  • Developmental therapeutics
  • Endocrine system cancer
  • Gastrointestinal cancer
  • Genitourinary cancer
  • Gynecological cancer
  • Hematological cancer
  • Head and neck cancer
  • Neurooncology
  • Pediatric oncology
  • Thoracic oncology
  • Sarcoma
  • Skin cancer
  • Epidemiology, cancer prevention, and cancer control
  • Supportive care
  • Imaging
  • Health care systems

We invite submission of all clinical trials, whether phase 1, 2, 3, or 4. For phase 1 trials, we especially encourage those that investigate a novel substance for a novel indication, a strong or unexpected beneficial or adverse response, or a novel mechanism of action.

We require registration of all interventional trials, whether early or late phase, in a primary register that participates in the WHO International Clinical Trial Registry Platform or in ClinicalTrials.gov, in accordance with the International Committee of Medical Journal Editors (ICMJE) recommendations.

Reports of trials must conform to the Consolidated Standards of Reporting Trials (CONSORT) 2010 guidelines and be submitted with a full protocol in English or with the full protocol and a synopsis in English that includes details of enrolment criteria, outcomes/endpoints, and statistical considerations.

All reports of randomized trials should include a section entitled “Randomization and Masking” within the Methods Section.

Editorial Board

Special Issues

Following special issues within this section are currently open for submissions:

Papers Published

Back to TopTop